ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.016,11
-0,64%
S&P 500
5.098,68
-0,34%
Dow Jones
38.221,42
-0,43%
Euro vs US Dollar
1,07034
-0,11%
Bitcoin
61.313,00
-3,95%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Rocket Pharmaceuticals Inc (RCKT)

  7. Rocket Pharmaceuticals Inc (RCKT) News

RCKT Rocket Pharmaceuticals Inc

21,76
-0,09 (-0,41%)
Zuletzt aktualisiert: 16:47:11
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Rocket Pharmaceuticals Inc RCKT NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
-0,09 -0,41% 21,76 16:47:11
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
21,57 21,44 21,98 21,85
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
02.4.202412:00BWRocket Pharmaceuticals Announces European Medicines Agency..
26.3.202421:01BWRocket Pharmaceuticals Announces Appointment of Aaron Ondrey..
05.3.202400:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202400:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.2.202421:54EDGAR2Form 144 - Report of proposed sale of securities
29.2.202420:59EDGAR2Form 144 - Report of proposed sale of securities
26.2.202422:37EDGAR2Form 8-K - Current report
26.2.202422:01BWRocket Pharmaceuticals Reports Fourth Quarter and Full Year..
22.2.202402:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.2.202402:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.2.202402:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.2.202402:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.2.202402:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202423:28EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
16.2.202422:37EDGAR2Form 144 - Report of proposed sale of securities
16.2.202422:31EDGAR2Form 144 - Report of proposed sale of securities
16.2.202422:26EDGAR2Form 144 - Report of proposed sale of securities
16.2.202422:22EDGAR2Form 144 - Report of proposed sale of securities
16.2.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.2.202422:37EDGAR2Form 8-K - Current report
13.2.202413:00BWRocket Pharmaceuticals Announces Update on FDA Review..
29.1.202421:26EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
23.1.202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.1.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.1.202421:16EDGAR2Form 144 - Report of proposed sale of securities
02.1.202422:01BWRocket Pharmaceuticals to Present at 42nd Annual J.P. Morgan..
13.12.202322:05EDGAR2Form 8-K - Current report
13.12.202302:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.12.202302:42EDGAR2Form 3 - Initial statement of beneficial ownership of..
12.12.202313:00BWRocket Pharmaceuticals Appoints R. Keith Woods to Board of..
17.11.202301:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.11.202301:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.11.202301:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.11.202300:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.11.202321:28EDGAR2Form 144 - Report of proposed sale of securities
16.11.202321:21EDGAR2Form 144 - Report of proposed sale of securities
16.11.202321:21EDGAR2Form 144 - Report of proposed sale of securities
07.11.202322:40EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06.11.202322:04BWRocket Pharmaceuticals Reports Third Quarter 2023 Financial..
25.10.202315:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.10.202321:19EDGAR2Form 144 - Report of proposed sale of securities
19.10.202313:00BWRocket Pharmaceuticals Announces Presentations Highlighting..
10.10.202322:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.10.202303:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.10.202322:05EDGAR2Form 8-K - Current report
02.10.202313:00BWRocket Pharmaceuticals Announces FDA Acceptance of Biologics..
26.9.202322:01BWRocket Pharmaceuticals to Participate in the Chardan 7th..
20.9.202322:09EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]

Kürzlich von Ihnen besucht

NASDAQ
RCKT
Rocket Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten